Stockreport

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Holdings Corp. - Class A  (WGS) 
PDF Data from more than 22,000 newborns reinforce GeneDx’s role spearheading the adoption of genomic newborn screening (gNBS) from research to clinical practice GAITHERSB [Read more]